AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Relmada Therapeutics Inc. (RLMD)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.44

0.00%

Pre-market Jan 07, 2025, 05:20 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.13K	7.94K
Cost of Revenue	n/a	n/a	1.26K	3.75K	n/a	4.87K	2.63K	85.27K	54.82K	9.26K	4.04K	5.80K
Gross Profit	n/a	n/a	-1.26K	-3.75K	n/a	-4.87K	-2.63K	-85.27K	-54.82K	-9.26K	1.09K	2.14K
Operating Income	-103.70M	-161.25M	-125.70M	-60.84M	-15.11M	-12.73M	-6.92M	-7.22M	-16.22M	-17.10M	-45.02K	-12.05K
Interest Income	n/a	2.66M	1.20M	1.40M	104.11	-761.04K	n/a	n/a	1.75K	10.88K	n/a	n/a
Pretax Income	-98.79M	-157.04M	-125.75M	-59.46M	-15.01M	-17.32M	-8.96M	-6.29M	-2.97M	-20.80M	-45.02K	-12.05K
Net Income	-98.79M	-157.04M	-125.75M	-59.46M	-15.01M	-17.32M	-8.96M	-6.29M	-2.97M	-20.80M	-45.02K	-12.05K
Selling & General & Admin	48.89M	47.93M	35.08M	24.87M	7.25M	5.70M	3.97M	5.93M	10.01M	9.23M	46.11K	13.82K
Research & Development	54.81M	113.32M	90.62M	35.97M	7.86M	7.02M	2.94M	1.29M	6.21M	7.87M	5.38M	n/a
Other Expenses	-293	6.35M	n/a	n/a	n/a	n/a	2.35K	216.21K	130.27K	n/a	n/a	n/a
Operating Expenses	103.70M	161.25M	125.70M	60.84M	15.11M	12.73M	6.92M	7.22M	16.22M	17.10M	46.11K	13.82K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	1.34M	550.00	n/a	4.92K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.03K	4.73K
Cost & Expenses	103.70M	161.25M	125.70M	60.84M	15.11M	12.73M	6.92M	7.22M	16.22M	17.10M	50.14K	19.62K
Income Tax	n/a	-2.66M	48.32K	-1.38M	-1	4.59M	2.05M	-716.10K	-13.11M	3.70M	-9.58M	-377
Shares Outstanding (Basic)	30.10M	29.63M	17.55M	15.59M	9.23M	6.31M	3.14M	3.02M	2.90M	2.49M	1.43M	1.43M
Shares Outstanding (Diluted)	30.10M	29.63M	17.55M	15.59M	9.23M	6.31M	3.14M	3.02M	2.90M	2.49M	1.43M	1.43M
EPS (Basic)	-3.28	-5.3	-7.16	-3.81	-1.63	-2.74	-2.86	-2.08	-1.03	-8.37	-0.03	-0.01
EPS (Diluted)	-3.28	-5.3	-7.16	-3.81	-1.63	-2.74	-2.86	-2.08	-1.03	-8.37	-0.03	-0.01
EBITDA	4.91M	-157.04M	-125.75M	-59.45M	-15.10M	-16.55M	-6.91M	-6.92M	-16.03M	-17.09M	-45.02K	-11.68K
Depreciation & Amortization	103.70M	2.00K	1.26K	3.75K	4.36K	4.87K	2.63K	85.27K	54.82K	9.26K	250.00	754.00